PeptideDB

Olinvacimab

CAS No.: 2095504-49-5

Olinvacimab (TTAC-0001), a fully human anti-VEGFR2 monoclonal antibody, demonstrates antiangiogenic activity by inhibiti
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Olinvacimab (TTAC-0001), a fully human anti-VEGFR2 monoclonal antibody, demonstrates antiangiogenic activity by inhibiting VEGF binding to KDR, with a dissociation constant (K d) of 0.23 nM. It is utilized in research for treating recurrent glioblastoma and breast cancer [1].
molecular weight N/A
CAS 2095504-49-5
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 years